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http:WHAT THIS PAPER ADDS
Objective/Background: This review intends to provide basic knowledge about X-ray physics, biological risks, dose
metrics, and radiation protection. It proposes standard nomenclature to measure, estimate, and report dose in
order to perform accurate comparisons between publications and practices. A literature review per common
procedure type with reference levels is also proposed to allow physicians to evaluate their daily practice.Context: Endovascular procedures, requiring X-ray guidance, are commonly performed in vascular surgery. X-ray
exposure is associated with biological risks for both patients and physicians. Medical X-ray use must follow “as
low as reasonably achievable” (ALARA) principles, which aim at using the lowest radiation exposure to achieve a
procedure safely. This is underlined by European and international recommendations that also suggest that
adequate theoretical and practical training is mandatory during the initial education of physicians. However, the
content of this education and professional practices vary widely from one country to another.
Objective: This review aims to summarize the basic knowledge required for vascular surgeons on X-ray physics
and image production.
Methods: A panel of endovascular therapists (vascular surgeons and radiologists) and physicists dedicated to X-
rays was gathered. International recommendations were summarized. A literature review was performed via
MEDLINE to identify studies reporting dosages of common endovascular procedures.
Results: The different mechanisms inducing biological risks, and the associated potential effects on health, are
described. Details on dose metrics are provided and a common nomenclature to measure, estimate, and report
dose is proposed in order to perform accurate comparisons between publications and practices. Key points of the
European and international legislation regarding medical X-ray use are summarized, and radiation protection
basics for patients and staff, are detailed. Finally, a literature review is proposed for physicians to evaluate their
practice.
Conclusions: Today’s trainees will be highly exposed to radiation throughout their practice. It is thus compulsory
that they undergo dedicated radiation education during their initial training, and regular refresher sessions later.
In daily practice, focus on dose reduction and monitoring of patient and staff exposure are mandatory.
 2015 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
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//dx.doi.org/10.1016/j.ejvs.2015.01.014training of physicians and staff exposed to occupational
radiation, with refresher sessions thereafter. Furthermore,
this basic radiation protection education needs to be
expanded for physicians performing procedures that are
routinely X-ray guided, such as vascular surgeons, inter-
ventional cardiologists, and interventional radiologists,2
with speciﬁc recommendations for the protection of pa-
tients from radiation. However, the content and credentials
of this training still vary widely from one country to another,
22 A. Hertault et al.and so do professional practices. For instance, in France in
2014, the national Nuclear Safety Agency issued a warning
to the medical community, as almost 70 exposure accidents
had been reported in the last few years, among which seven
were regarded as severe accidental occupational exposures.
This review intends to summarize the basic knowledge
required for vascular surgeons about X-ray physics, biolog-
ical risks, dose metrics, and radiation protection. It proposes
standard nomenclature to measure, estimate, and report
dose in order to perform accurate comparisons between
publications and practices. A literature review per common
procedure type with reference levels is also proposed to
allow physicians to evaluate their daily practice.BASIC KNOWLEDGE
X-ray physics and image formation
X-ray imaging is based on the seemingly simple physics of
the interaction of X-rays with matter. X-rays are both elec-
tromagnetic waves and particles (photons) that move along
straight lines in vacuum. They are powerful enough to
penetrate deeply in matter and are able to cross it in certain
conditions. In humans, the distribution of the amount and
nature of matter is dependent on the anatomy, thus of-
fering different interaction characteristics with X-rays
allowing a bi-dimensional projection or shadow image when
X-rays are emitted from a point source. The shadow image is
obtained as certain parts of the body are more transparent
to X-rays than other parts. In all cases, some X-rays are
absorbed (entirely or partially) by the body. This absorption
effect is called the radiation dose and thus it is inherent to
X-ray imaging to create a radiation dose to the patient.
Radiation dose is evaluated as the energy released in a
reference matter. For entrance dose before the skin, the
reference material is the air; therefore:
Air kerma (kinetic energy release in matter) is the dose
delivered by the X-ray beam to a volume of air, measured in
Gray.
Gray (Gy) One Gy is equal to 1 J/kg. In itself, the energy
released in matter is quite small; it takes 4.18 J to raise 1 g of
water by 1 C so that a dose of 1 Gy entirely transferred into a
temperature change would raise the temperature of the
irradiated water by 0.00024 C. Unfortunately, the energy
released in matter has other effects; the mechanism of
creating harm from a radiation dose is described in the sec-
tion “Biological risks, stochastic and deterministic effects”.
Sievert (Sv) is the unit used to evaluate the impact of
biological ionizing radiation on biological tissues. In the
speciﬁc case of X-rays, and in biological conditions, 1 Gy is
equal to 1 Sv.
There are several types of X-ray interactions with matter:
 no interactiondthe X-ray simply goes through the
matter without interacting with it; simple change in direction, called elastic scatterdthe X-
ray is deviated without a change in energy;
 change in direction and energy, called inelastic scatter or
Compton scatterdthe X-ray leaves a part of its energy in
the matter and emerges from it in a different direction;
 complete absorption, called photoelectric effectdthe X-
ray energy is completely transferred to the matter.
The scatter effects have two consequences: they create
X-rays that do not originate from the same point source,
thus blurring the shadow image for scattered X-rays in the
direction of the image; for scattered X-rays that are in other
directions, this creates X-rays that may reach people located
close to the patient, thus creating operator dose.
Equipment that produces X-ray images are essentially
composed of an X-ray tube, an image detector with an anti-
scatter device on the other side, and a table between them
supporting the patient. An X-ray tube emits X-ray photons
with a continuum of different energies where the highest
energy (in keV) corresponds to the highest voltage applied
to the X-ray tube (kVp).
Biological risks, stochastic and deterministic effects
As stated previously, part of the X-ray beam energy is
absorbed by the patient. This induces the release of energy
in tissues at the origin of biological effects, mediated by two
mechanisms.3 First, there is direct cellular damage, mostly
represented by direct DNA breakage, especially in imma-
ture, undifferentiated, or dividing cells, such as stem cells.
At low dose exposure, DNA repair mechanisms can restore
those alterations, but high dose exposure can result in an
accumulation of abnormalities, leading to apoptosis and
clinical manifestations. Second, indirect cellular damage:
ionizing radiation is also responsible for water hydrolysis
within the cell. This leads to the formation of hydroxyl
molecules (free radical), which combine to form reactive
oxidative species such as hydrogen peroxide. Those reactive
species tend to bind to proteins to form stable complexes,
but this induces loss of essential protein function, and, ul-
timately, cell apoptosis. Up to two thirds of radiation
induced DNA damage could be attributed to this
mechanism.3
Secondary to these phenomena, two types of biological
effects can be seen, with different clinical outcomes. The
“deterministic effects” appear once a threshold is over-
stepped, and their clinical severity is correlated with the
intensity of the exposure. Essentially, they represent a risk
for patients’ skin and hair, and physicians’ lenses. On the
contrary, the onset of “stochastic effects” is not associated
with a particular threshold, and so cannot be predicted, but
the likelihood of occurrence increases with exposure. They
mainly concern repeatedly exposed physicians or staff and,
to a lesser extent, patients.
Deterministic effects. The most common manifestation of
deterministic effects is cutaneous, and often referred to as
radiation induced “skin injury”, or radiation dermatitis.4
Frequency is estimated to be between 1:10,000 and
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clearly under-diagnosed because (i) clinical manifestation is
often delayed after the procedure (from 2 weeks to 2
years); (ii) injuries are mostly located at the beam entrance
point to the skin, so on the patient’s back, and rarely linked
to the X-ray exposure; (iii) physicians’ knowledge of this
complication is heterogeneous and follow up is infrequently
suitable to diagnose it, even in at risk patients. Determin-
istic effects were initially described after extreme exposure
following nuclear accidents or radiotherapy, but can also
occur after ﬂuoroscopy guided procedures.6 Thus, in 2000,
Koenig et al. listed 73 reports of skin injuries following
ﬂuoroscopy guided procedures in the literature (>90% were
reported between 1996 and 2000), essentially after endo-
vascular procedures.7
Deterministic effects typically occur once a threshold
level of exposure is overstepped, with a clinical severity well
correlated to the intensity of the exposure. Thus, after ex-
posures >2 Gy, transient erythema can appear, while severe
tissue loss can be observed with higher exposure. The
American National Cancer Institute has deﬁned ﬁve severity
grades to classify those injuries (Table 1).8
Regarding the onset delay of clinical manifestations, they
can be stratiﬁed as prompt (<2 weeks after the procedure),
early (2e8 weeks), mid-term (6e52 weeks) and long-term
(>40 weeks) reactions. Dose thresholds are given for in-
formation purposes, but sensitivity and clinical events onset
vary from one individual to another.
Prompt reactions are mostly represented by transient
erythema, at the beam entrance point. According to the
authors, it appears from 24 h to 2 weeks after an exposure
of >2 Gy.6,9 It spontaneously resolves in a few days in most
cases, but, if observed, this reaction must be considered
alarming and prompt physicians to schedule a speciﬁc
follow up.
Early reactions appear after an exposure of >6 Gy.6,9
They are consecutive to stem cells injuries in the basal
layer of the epidermis. The ﬁrst manifestation is a sustained
erythema, associated with inﬂammatory signs such as
itching pain and oedema. If the exposure is not much more
than 6 Gy, this manifestation can fade in a month; other-
wise, particularly if doses >10 Gy, it can evolve to a chronic
injury with dry or moist desquamation, and epilation with
dermal atrophy.
Mid-term reactions are due to blood vessel wall or sub-
cutaneous fat injuries following exposure to radiation
>10 Gy.10 Depending on the exposure severity, the initial
erythema evolves to reveal from ischemic dusky areas to
full dermal necrosis (>15 Gy) requiring surgical
intervention.Table 1. Classiﬁcation of radiation induced skin injuries (American Nat
Grade 1 2 3
Symptoms Faint erythema or
dry desquamation
Moderate to brisk erythema;
patchy moist desquamation,
mostly conﬁned to skin
folds and creases; moderate
edema
Moist d
other th
creases
by minoLong-term reactions include different manifestations such
as dermal atrophy with permanent induration or radiation
induced telangiectasia (following sustained erythema and
moist desquamation) or severe and persistent tissue losses
(after exposure > 15 Gy).
A schematic overview of the relationship between dose,
delay, and clinical manifestations is given in Fig. 1.
Risk factors. Several risk factors, correlated with an incre-
ment of the likelihood and severity of skin injuries, have
been reported.
Risk factors related to the patient. Risk factors related to
the patient are essentially represented by active smoking,
nutritional depletion, diabetes mellitus, hyperthyroidism,11
compromised skin integrity of the exposed area, and
obesity or overlapping skin folds, as more energy is required
to go through the ﬂesh.7 Some skin locations are also
known to be more radiosensitive,4 such as the anterior part
of neck or the tibia, or ﬂexor surface of extremities, as the
skin is thinner. Hair follicles of the scalp are more sensitive
than follicles in other areas.
Associations with genetic diseases, especially mutations
that reduce DNA repair capabilities, have also been re-
ported. An example is ataxia telangiectasia, an autosomal
recessive disorder after homozygous mutation of ATM. It
has been suggested that patients with severe, unanticipated
skin injuries after X-ray exposure could carry a heterozygous
mutation of ATM, which would affect approximately 1% of
the general population.4
Some connective diseases such as scleroderma or sys-
temic lupus erythematosus could also induce a higher
sensitivity to X-ray exposure; however, few cases are re-
ported and this remains controversial.
Finally, several drugs, in particular chemotherapy agents,
for example actinomycin D, doxorubicin, bleomycin, 5-
ﬂuorouracil, or methotrexate, increase the likelihood of
skin injuries.9 However, molecules such as 3,30-diindolyl-
methane could confer protection against ionizing
radiation.12
Risk factors related to the procedure. All factors likely to
increase the exposure to radiation during a procedure might
increase the rate of skin injuries. However, factors speciﬁc
to the onset of deterministic effects have been identiﬁed,
such as prolonged exposure to the same skin entrance
point, overlapped areas of irradiated skin, and repeated
exposure to the same area at short intervals, before DNA
reparation can occur.
Speciﬁc risk for physicians. The lens is a highly radiosensi-
tive tissue. Acute or chronic exposure to X-rays may mani-
fest as radio-induced cataracts (RICs), with typical cortical orional Cancer Institute)8.
4 5
esquamation in areas
an skin folds and
; bleeding induced
r trauma or abrasion
Life threatening consequences;
skin necrosis or ulceration of
full thickness dermis; spontaneous
bleeding from involved site; skin
graft indicated
Death
Figure 1. Schematic overview of the relationship between dose (entrance skin dose [ESD]), delay and clinical manifestations.6,9,13 Red
boxes illustrate time and dose thresholds between which the clinical manifestations might occur; however, they do not represent absolute
values, and effects could be observed outside of the limits.
24 A. Hertault et al.posterior subcapsular opacities.3 Until recently, RICs were
considered to be a deterministic effect occurring when lens
doses exceeded 6e8 Gy over a short period; however, the
International Commission on Radiological Protection (IRCP)
has recently revised this threshold to 0.5 Gy.13 Indeed, this
speciﬁc radiation related complication is of growing concern
as recent studies have demonstrated an increased incidence
of those opacities in interventional physicians.14,15 Accord-
ing to Jacob et al.,16 interventional cardiologists present a
higher risk of developing posterior subcapsular lens opaci-
ties than unexposed workers (17% vs. 5%, p ¼ .006; odds
ratio 3.9 [95% conﬁdence interval 1.3e11.4]), but this risk
becomes non-statistically signiﬁcant if appropriate protec-
tion glasses are used routinely.
Stochastic effects. A stochastic effect is a probabilistic event
whose occurrence is not threshold dependent. Its onset
increases proportionally to the intensity of the exposure,
but not its severity. Essentially, stochastic effects induce the
development of solid cancers and leukemia, or malforma-
tions in offspring, several months or years after the expo-
sure. The probability of stochastic effects depends of the
radiosensitivity of the exposed tissue or organ. The absor-
bed dose (Gy) can be converted into effective dose (ED; in
Sv) through mathematical simulation (Monte-Carlo) and
consensual conversion factors, speciﬁc to each organ, in
order to include the tissue sensitivity in the risk estimation.
For example, the tissue weighting factors proposed by the
IRCP are 0.12 for breast and 0.01 for brain,13 meaning
breast tissue is more radiosensitive than brain.
Follow up of the survivors of the Hiroshima and Nagasaki
atomic bombings has concluded that solid cancer incidence
increases in proportion after exposition from high tomoderate radiation dose.17 In the ﬁeld of medical applica-
tions, radiation doses are considered to be low to very low
(100 mSv). However, according to the Biological Effects of
Ionizing Radiation VII (BEIR VII) report, below 100 mSv the
likelihood of the occurrence of stochastic effects remains
proportional to the exposure and is not threshold depen-
dent, so that even the lowest exposure would increase the
risk to a human.18 This is known as the “linear no-
threshold” model. Therefore, based on this model and even
if stochastic effects cannot be formally predicted, the BEIR
VII committee has suggested a mathematical simulation to
estimate a lifetime attributable risk (LAR) of cancer devel-
opment after low-dose exposure. For example, the LAR
following a coronary computed tomography (CT) scan in a
80 year old woman would be 0.075% (one induced cancer
for 1338 scans), but would rise to 0.7% (one cancer induced
for 143 examinations) for a 20 year old woman.
Consequently, patients undergoing diagnosis or inter-
ventional X-ray based imaging for medical purposes are at
risk, but even more so physicians who are repeatedly
exposed to small doses. Indeed, for a physician performing
100 peripheral angiographic procedures per year, the
annual dose has been estimated to be up to 40 mSv to the
eye and 30 mSv to the head,19 and up to 6 mSv under
protective aprons.20 This can be compared with annual
environmental exposure, which has been estimated to be
between 1 and 3 mSv; the limit usually set for exposed
workers is around 100 mSv over 5 years (or 20 mSv per
year). According to the BEIR VII report, after 15 years of
practice, a physician receiving 2e5 mSv per year has a LAR
of cancer estimated around one in 200.20
Thus, as early as 1944, concern was raised among radi-
ologists as published evidence suggested a 10 fold increase
Table 2. Dose area product conversion factors.
Unit Conversion factor to Gy.cm2
(divide by)
dGy.cm2 10
mGy.m2 0.1
cGy.cm2 100
mGy.cm2 1000
mGy.m2 100
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side, have since also been reported among interventional
cardiologists or radiologists,22 but evidence is still lacking to
support the fact that the incidence of cancer is increased in
this exposed subset when compared with the general
population.
Pregnancy. During pregnancy, the development of child-
hood cancer, secondary to in utero exposure to radiation, is
the main feared stochastic effect. The embryo’s sensitivity
to X-rays depends on precocity and the amount of expo-
sure. Therefore, it is recommended that fetal exposure is
kept as low as possible, and thresholds of 5 mSv during an
entire pregnancy or 0.5 mSv per month have been sug-
gested by the National Council on Radiation Protection &
Measurements (NCRP).23 Indeed, with an exposure of
<50 mSv, the risk to the fetus is generally considered low;24
however, in 2008 the IRCP recommended lowering this
threshold to 1 mSv.13 In addition to the previously
mentioned stochastic risks, speciﬁc deterministic risks such
as intrauterine growth retardation, mental retardation, or
small head size have also been reported during pregnancy.25
Exposure of the embryo in the ﬁrst days after conception
can lead to miscarriage.
DOSE METRICS AND MEASUREMENTS
Monitoring patient exposure
Indirect dose measurements. Interventional ﬂuoroscopy
systems are capable of displaying one or more of the
following items related to patient dose:
 ﬂuoroscopy time (FT);
 dose area product (DAP);
 cumulative air kerma (CAK) at the reference point.
Although these indicators do not measure the patient
dose directly, they are intended to give the interventional
physician enough dose information in real time during the
procedure in order to monitor patient dose.
Fluoroscopy Time (FT), is displayed on all interventional
ﬂuoroscopy systems. FT is a counting of the time spent using
ﬂuoroscopy and therefore can be useful as a quality assur-
ance tool for assessing the efﬁciency of a physician in
completing a procedure. FT has shown poor correlation with
the other dose indicators.26e28 FT has major limitations as it
does not supply any information regarding the system
setting, X-ray ﬁeld size or position, or the dose contribution of
ﬂuorographicmodes.Therefore, this indicator should be used
carefully and only if no other metric is available.29,30 Inaddition, FT is calculated differently depending on the system
andmanufacturer. It can be a total pedal time or only the sum
of X-ray pulses when pulsed mode is used.
DAP, or kerma area product, is deﬁned as the product of
the air kerma (the energy extracted from an X-ray beam per
unit mass of air) by the area of the cross section of the X-ray
beam. It is a surrogate measurement for the entire amount
of energy delivered to the patient by the beam, measured
in Gy.cm2.31 A conversion table is included to compare units
reported by most systems (Table 2).31
DAP display has been required by the European Union
since the early 2000s. DAP correlates poorly with the skin
dose for individual patient procedures.32e34 DAP is more
reliable as an estimator of energy imparted to the patient
and therefore of stochastic risk. As this indicator was
introduced on ﬂuoroscopy equipment a long time ago, it
has been widely used for comparing doses among pro-
cedures performed in the same anatomic region and be-
tween different institutions.
Cumulative air kerma (CAK) (or cumulative dose or
reference point air kerma [Ka,r]; displayed in Gy) was
introduced by the International Electrotechnical Commis-
sion in 2000.35 It is the air kerma accumulated at a speciﬁc
point (called reference point) in space relative to the ﬂuo-
roscopic gantry. The reference point has been deﬁned on
the central axis of the X-ray beam, 15 cm from the isocenter
towards the X-ray tube side for isocentric C-arms. The
location of the reference point changes with the rotation of
the gantry and therefore the air kerma is summed over the
full surface of a 15 cm radius sphere representing a 30 cm
diameter patient. This concept was later adopted as part of
the reference US Food and Drug Administration perfor-
mance standard for medical X-ray ﬂuoroscopy systems.36
The aim of monitoring the CAK at the reference point was
to provide a way of estimating the dose at the patient’s skin
in order to avoid deterministic effect due to high dose ra-
diation during the procedure. To support this intended use,
the NCRP has published a report in which it recommends
using the CAK rather than FT or DAP for procedures that
require high doses of radiation.30 However, the CAK has
limitations related to the size and position of the patient.
Depending on the patient’s size and the table height, the
reference point may be outside or inside the patient. In
addition, CAK and DAP measures ignore the effect of the
backscatter from the patient, which can increase the skin
dose by about a third, depending on the beam area and
energy.37
Direct dose measurements. The previously mentioned in-
dicators (FT, DAP, and CAK) are indirect measurements of
dose.38 These methods do not provide the dose at a speciﬁc
point on the patient. Point measurements can be obtained
with instruments placed directly on the patient.
Entrance skin dose (ESD, in Gy) is the dose absorbed by
the skin at the entrance point of the beam. At the most
irradiated area (from primary beam and scatter), it is called
peak skin dose (PSD). It can be measured with either
thermoluminescent dosimeters (TLDs),38e41 radiochromic
26 A. Hertault et al.ﬁlms,42e45 or optically stimulated luminescence dosimeters
(OSLDs; Landauer, Inc., Glenwood, IL, USA).46e48
Modeling and risk estimation
Deterministic effect estimation Direct measurements
deliver relevant dose information but they do not provide
real time data during the procedure. For two decades,
several research projects have worked on automated pa-
tient skin dose monitoring during procedures.49e54 Manu-
facturers have developed tools to display in real time a map
displaying the dose distribution on a patient model,
adapted to different patient sizes. The dose calculations are
made by correcting the air kerma at the reference point to
the actual position of the patient and by taking into account
the system geometry, the backscatter from the patient, and
the attenuation of the table.
Stochastic effect estimation. The Effective Dose (ED, in Sv)
is the sum of the absorbed dose by various organs weighted
by tissue factors according to their radiosensitivity. A list of
the tissue weighting factors has been proposed by the
IRCP.13 A rough estimation of the ED can be obtained
computationally through mathematical Monte-Carlo simu-
lations on a virtual body. It is often used to determine a
gross estimation of the occurrence of stochastic risks in an
average individual of an irradiated population. Conversion
factors to obtain a very rough evaluation of the ED on an
anatomical area, like the abdomen, in speciﬁc settings have
also been suggested in the literature.55Monitoring staff occupational exposition
ED to the operator can be reported in Sv. Individual do-
simeters report a personal dose equivalent, Hp(d), deﬁned
by the ICRP as the dose equivalent in soft tissue at an
appropriate depth, d, under the dosimeter. Estimation of
the occupational ED (E) can be performed with two
dosimeter measurements (one above and one under the
lead apron) with the following formula: E ¼ 0.5 Hw þ 0.025
Hn, as recommended by the IRCP (where Hw and Hn are
under and above the lead apron, respectively). Passive
dosimeters do not provide direct readouts and can operate
without any active means. Examples are ﬁlm badges, TLDs,
and OSLDs. Measured dose equivalent is usually taken as an
estimate for the ED, which is recorded and reported after
evaluation. As opposed to a passive dosimeter, active do-
simeters provide a direct display of the accumulated dose
and dose rate, as well as some additional functions such as
alarm threshold settings for dose or dose rate values. The
active dosimeter allows medical staff to adjust their
behavior and avoid unnecessary occupational radiation
exposure.How should dose values be reported?
In order to perform dose comparisons, it is mandatory to
propose a standard nomenclature to report dose data.
FT (min) can be used when no other indicators are
available, but it correlates poorly with biological risk. It is
mostly correlated with the complexity of the procedure.An estimation of the deterministic effects risk should
always be performed by reporting the CAK (in mGy or Gy).
Optimal reports can be performed with both direct and
accurate measurements of the PSD or ESD (in mGy or Gy),
for example with radiochromic ﬁlms positioned under the
patient. These can also be used to determine conversion
factors to further estimate the skin dose from indirect
measurements.
DAP (in Gy.cm2) can provide a ﬁrst estimation of the risk
of stochastic effects. The best analysis can be performed
with estimation of the ED (Sv) per organ, using Monte-Carlo
simulations, or more roughly by anatomic region using
conversion factors.
Therefore, FT (min), DAP (Gy.cm2), and CAK (mGy) must
be included in the procedure’s report. As FT calculation can
vary from one system to the other, the characteristics of the
imaging system should also be included.When X-ray devices
are equipped with automated patient skin dose monitoring
software, estimated skin dose map and PSD should also be
included (Fig. 2).
In order to ensure data comparability, publications on
radiation should include at least the CAK and DAP. Values
provided by the X-ray equipment must be checked and
corroborated by direct dose measurements of radiation
exposure, for example with the radiochromic ﬁlm
approach.45,56 Better assessment of deterministic and/or
stochastic risks should be provided by direct measurements,
or estimations, of PSD and ESD or ED respectively.LEGISLATION AND INTERNATIONAL RECOMMENDATIONS
Euratom treaty
This European Directive recalls basic safety standards for
protection against the dangers arising from exposure to
ionizing radiation and emphasizes several points:1
 Justiﬁcation, optimization, and dose limitation. The
individual beneﬁt of radiation exposure should
outweigh the health detriment that it may cause. The
radiation protection should be optimized with the aim of
keeping the likelihood of exposure and the number of
individuals exposed as low as reasonably achievable
(ALARA). In planned exposure situations, the sum of
doses to an individual should not exceed the dose limits
and reference levels should be established.
 Quality control. Imaging system calibration, including
dosimeter calibration, must be performed before ﬁrst
medical use, and should be performed after each
maintenance. Periodic quality controls and evaluation of
image quality are strongly recommended.
 Patient information. Any medical exposure takes place
under the clinical responsibility of a practitioner. He/
she should provide adequate information to the patient,
relating to the beneﬁts and risks (short- and long-term
health risks) associated with the radiation dose,
especially when the expected radiation of the procedure
is high, or when the patient presents risk factors for skin
injury.57
Figure 2. (A) Example of a standard procedure report with basic data that should be recorded; and (B) skin dose cartography from skin dose
modeling software (DoseMap, GE Healthcare, Little Chalfont, UK).
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Table 3. Dosimetric data reported following standard and complex aortic endografting.
First author Year n FT (min) Median DAP (Gy.cm2) Median ESD (mGy) Median PSD (mGy) Median ED (mSv) Details
Dose reported for abdominal aortic endografting
Geijier77 2005 24 21.4 (7.4e78.9)a 60.1 (16.6e195)a 330 (85e1,100)a 8.7 (2.5e28.1)a
Ho78 2007 30 12.7c
Weiss79 2008 12 20.6 (12.6e34.2)b 151.7 (52.1e245.4)b 750 (270e1,250)b
Weerakkody80 2008 96 21 (16e31) 0$85 (0.51e3.74) 27 (16e117)
Kalef-Ezra63 2009 62 18 (4.3e75)a 37.4 (9e139)a
Kuhelj81 2010 172 17 (2.9e97.8)a 153 (35e700)a 440 (120e2,730)a
Jones82 2010 320 29.4  23.3 d 46.9  28.4 d 11.7 (0.3e51.2)b
Howells83 2012 630 18 (2.4e161) 173 (109.4e3343.4)a 710 (440e1,370)a 53 (33e1,000)a
Walsh84 2012 111 18.5c 85.8c 690c 12.4
Maurel56 2012 188 9.36 (1.76e67.1)a 30 (4.3e280)a
Peach69 2012 57 20.0 (4.8e49.3)a 69 (19.1e950)a Nonoperator-controlled
imaging
65 16.2 (3.1e51.1)a 49 (12.5e133)a Operator-controlled
imaging
Fossaceca85 2012 153 78 (27e370) 400 (10e200) 16 (5e85)
Patel86 2013 26 19.5 (14.4e31.5) 97.3 (55.4e167.9)
Blaszak87 2014 266 271 (37e1,760)b Men
2014 31 276 (64e625)b Women
Hertault45 2014 44 10.6 (9.1e14.7) 12.2 (8.7e19.9) 63 (44e103) 3.5 (2.5e5.6)
Dose reported for thoracic endografting
Howells83 2012 232 10 (1.5e130.0)a 194 (112.8e3,510.1)a 800 (460e1,440)a 58 (34e110)a
Majewska88 2012 100 10.6 (0.8e48.1)a 309 (44e1,355)a
Maurel56 2012 28 7.75 (1.16e19.1)a 20 (2.6e110.0)a
Patel86 2013 10 9.0 (6.4e23.3) 191.1 (137.4e300.6)
Hertault45 2014 14 8.9 (6.0e10.5) 26.0 (11.9e34.9)
Dose reported for complex aortic endografting
Panuccio89 2011 18 140.7  64.4 d 1,005.7  627.8 d 3,200  1,600 c 127.6 (33.2e373.8) BEVAR TII and TIII
29 81.9  45.8 d 642.5  311.6 d 2,200  1,300 c 103.1 (24.5e218.1 BEVAR TIV
Howells83 2012 53 58 (6.7e212.0)a 320.6 (172.1e2133.2) 1,300 (700e8,700)a 96 (5.2e640.0)a BEVAR/FEVAR
Maurel56 2012 54 27.2 (2.1e69.1)a 72.8 (11.0e290.0)a FEVAR
20 42.98 (2.38e95.5)a 159.5 (29.8e777.0)a BEVAR
Tacher90 2013 9 82  46d 1,188  1,067d BEVAR/FEVAR 2D
14 42  22d 984  581d BEVAR/FEVAR 3D
14 80  36b 656  457b BEVAR/FEVAR FUSION
Hertault45 2014 18 30.7 (20.2e40.5) 43.7 (24.7e57.5) 12.7 (7.2e16.7) FEVAR
20 39.5 (34.8e51.6) 47.4 (37.2e108.2) 13.7 (10.8e31.4) BEVAR
Note. Values are given as mean  interquartile range unless otherwise indicated. FT ¼ ﬂuoroscopy time; DAP ¼ dose area product; ESD ¼ entrance skin dose; PSD ¼ peak skin dose;
ED ¼ effective dose; op: operator; FEVAR ¼ fenestrated endovascular aortic repair; BEVAR ¼ branched endovascular aortic repair; 2D ¼ two dimensional; 3D ¼ three dimensional.
a Median (range).
b Mean (range)
c Mean.
d Mean  SD.
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Table 4. Dosimetric data reported following iliac and lower limb angioplasty/stenting.
First author Year n FT (min) Median DAP (Gy.cm2) Median CAK (mGy) Details
Iliac arteries
Miller27 2003 24 13.4 (3.3e25.4)a 164 (206e301)a 885 (189e1,562) RL, USA, no stent
93 18.4 (4.6e66.4)a 213.0 (11.5e886.5)d 1,335 (211e4,567) RL, USA, stent
Aroua91 2007 72 19.2 (2.0e66.0)a 344 (36.0e1,122)a RL, Switzerland
Stratakis92 2007 56 14.4  4.8 b 127  52 b 990  392 b
Vano93 2009 70 6.5 (1.3e67.1)c 53 (14.1e1,136)c RL, Spain
Majewska88 2012 42 4.7 (2.9e6.0) 43 (29e76) 126 (103e194) TASC A
52 6.6 (3.9e9.9) 99 (67e137) 345 (258e508) TASC B
66 9.0 (6.1e13.2) 162 (127e261) 591 (385e844) TASC C
Segal94 2013 98 11 (8e20) 179.6 (81.2e343.2)
Superﬁcial femoral artery
Kocinaj95 2006 100 49 (37e73)
Majewska88 2012 16 6.9 (5.6e9.2) 6 (4e8) 31 (22e40) TASC A
20 9.6 (6.8e13.5) 11.7 (8e18) 64 (48e70) TASC B
27 13.2 (10.0e17.1) 46 (28e103) 168 (104e330) TASC C
Segal94 2013 95 16 (10e31) 63.2 (18.9e109.6)
Popliteal artery
Majewska88 2012 27 12.7 (9.6e22.9) 46 (14e48) 203 (72e131)
Infrapopliteal arteries
Segal94 2013 62 31 (20e51) 28.9 (16.6e72.9)
Multi-level
Segal94 2013 109 36.1 (21.8e48.5) 49.5 (24.7e119.1)
Note. Values are given as Median (interquartile range) unless otherwise indicated. FT ¼ ﬂuoroscopy time; DAP ¼ dose area product;
CAK ¼ cumulative air kerma; RL ¼ reference level; no stent ¼ angioplasty without stenting; stent ¼ angioplasty with stenting.
a Mean (range).
b Mean  SD.
c Median (range).
d Mean (IQR).
Minimizing radiation exposure during endovascular procedures 29 Recording and reporting of doses from medical
procedures. All radiation data should be kept in the
patient medical records (ideally DAP and PSD, or CAK if
PSD not available).29
 Utilization of diagnostic reference levels.
 Availability of dose indicating devices. The IRCP
recommends wearing two dosimeters, one under the
lead apron, at chest level (to estimate the dose to the
organs under the shielded region), and a second one
outside the lead apron at the level of the collar or the
left shoulder (to estimate the dose received in
unshielded regions, especially the head).57 An additional
dosimeter for the hands can be used. The limit on the ED
for occupational exposure is 20 mSv in any one year. The
limit on the ED for public exposure is ﬁxed at 1 mSv per
year.
Vascular surgeons are classiﬁed as category A exposed
workers (they are likely to receive an ED > 6 mSv per year,
or an equivalent dose > 15 mSv per year for the lens of the
eye or > 150 mSv per year for skin and the extremities).
They should be systematically monitored based on indi-
vidual measurements obtained by a dosimetry service, and
a record containing the results of individual monitoring
should be made. An adequate system for monitoring the
exposure of the lens of the eye or extremities should also
be set up. Annual medical surveillance is required.Learning outcomes for physicians directly involved with
the use of radiation59
As lack of training in radiation protection may present risks
to staff and patients, the IRCP recommends a level of
training in radiation protection commensurate with the use
of radiation.2
Accreditation, certiﬁcation, and recognition of medical
education and training in radiation protection. External
assessment of the quality of education or training provision
is needed,60 and can be achieved in different ways:
 Accreditation should be based upon established
standards and guidelines. A recognized body assesses
and recognizes that education and/or training in medical
radiation protection provided by an institution meets
acceptable levels of quality.60 All staff should possess
appropriate qualiﬁcations and experience in medical
radiation protection. Considering the rapid technological
developments and the complex science involved in
modern imaging procedures, the development of “train
the trainer” schemes is crucial. Scientiﬁc program
content and educational material should also be
reviewed periodically to remain current.
 Recognition. A national authority recognizes the
professional equivalence of foreign higher education
diplomas or other evidence of formal qualiﬁcations
Table 5. Dosimetric data reported following renal/visceral angioplasty/stenting.
First author Year n FT (min) Median DAP (Gy.cm2) Median CAK (mGy) Details
Miller27 2003 53 16.5 (3.1e106.6)a 157.5 (26.2e1,040.8)a 1,183 (157e5,482)a RL, USA,
renal/visceral, no stent
103 21.6 (4.1e86.9)a 190.00 (9.83e724.20)a 1,605 (104e7,160)a RL, USA,
renal/visceral, stent
Stratakis92 2007 24 16.9  13.4 b 176  46 b 1,193  547 b Renal
Majewska88 2011 22 11.6 (9.6e20.1) 145 (96e207) 658 (454e820) Renal
McBride96 2013 134 15.6  10.8b 1,729.0  1,253.2b Renal
Note. Values are given as median (interquartile range) unless otherwise indicated.
FT ¼ ﬂuoroscopy time; DAP ¼ dose area product; CAK ¼ cumulative air kerma; RL ¼ reference level; no stent ¼ angioplasty without
stenting; stent ¼ angioplasty with stenting.
a Mean (range).
b Mean  SD.
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30 A. Hertault et al.awarded upon the completion of a course at a higher
education institution.
 Certiﬁcation is usually based on examinations. A medical
professional, who has demonstrated special knowledge
and expertise in medical radiation protection, and has
successfully completed the education or training
provided by an accredited organization, is recognized as
certiﬁed medical personnel. Knowledge and conﬁdence
in the ﬁeld of medical radiation protection, enables them
to justify and optimize medical procedures to provide
better patient care. Certiﬁcation is only for a limited
period of time, 3e5 years, and is usually based on oral or
written examinations.RADIATION EXPOSURE DURING ENDOVASCULAR
PROCEDURES
PubMed and Medline search were performed to identify all
series reporting radiation data for standard endovascular
procedures. Studies reporting dose records and/or proce-
dure detail methodology poorly were excluded. Radiation
data for each procedure are summarized in Tables 3e7
Published reference levels are also reported. The concept
of “reference levels” was ﬁrst introduced for diagnostic
radiology by the ICRP in 1990.61 It was then proposed for
interventional procedures. The purpose of reference levels
is advisory. They help identify unusually high levels, and
help to increase practitioner awareness of patient dose
values and of radiation protection. Reference levels are
determined by calculating the 75th percentile of radiation
dose values (DAP, CAK, etc.), per procedure type, from
measurements performed on a sample of representative
centers. To be accurate, a large number of registrationsable 6. Dosimetric data reported following carotid angioplasty/stenti
First author Year n FT (min)
Miller27 2003 18 40.5 (18.5e64.5)a
Kocinaj95 2006 50
Majewska88 2012 73 13.2 (10.3e17.3)
D’Ercole97 2013 93 23b
ote. Values are given as median (IQR) unless otherwise indicated. FT ¼
erma; RL ¼ reference level.
Mean (range).
Mean.must be made for each type of examination. The choices of
reference levels take into account both radiological pro-
tection requirements and societal criteria.
RADIATION PROTECTION
The risk beneﬁt ratio of X-ray use in medical practice has to
be taken in account for each patient and procedure. This
concept is referred to as the ALARA principle.62 It is
mandatory to adapt strategies to the patient’s age, as
iterative X-ray based procedures and follow up may repre-
sent a real “radiation burden” over a lifetime.63 Therefore,
X-ray based strategies must be replaced by non-X-ray ones,
like duplex ultrasound, every time this is possible.
Dose reduction during procedures
During most interventional procedures, X-ray use is still
mandatory. Following the ALARA principle, every effort
should be made to limit the exposure of patients and
physicians, while maintaining image quality, and thus the
safety and efﬁciency of the intervention.
Pulse mode. In pulsed mode, images are obtained via
multiple short X-ray pulse emissions, as opposed to
continuous ﬂuoroscopy. Digital image display at a constant
frame rate is used to compensate the loss of temporal
resolution and obtain a smooth shift between each image.
At a typical frame rate of 7.5 images/s, a 90% reduction of
produced images is observed compared with continuous
mode, and so an equivalent dose reduction is seen
(assuming exposure settings are the same in pulsed and
continuous mode).45 Therefore, the frame rate must be
adapted to each procedure type in order to be the lowest
possible.ng.
Median DAP (Gy.cm2) Median CAK (mGy) Details
167.9 (31.9e515.4)a 1,382 (326e4,405) RL, USA
46 (33e70)
42 (25e67) 273 (196e429)
213b
ﬂuoroscopy time; DAP ¼ dose area product; CAK ¼ cumulative air
Table 7. Dosimetric data reported following visceral embolization.
First author Year n FT (min) Median DAP (Gy.cm2) Median CAK (mGy) Median ESD (mGy) Details
Miller27 2003 94 25.8 (3.5e93.7) 347.6 (27.1e1294.7) 2,367 (105e7,160) RL, USA, GI
Livingstone98 2005 9 14.9 (3.1e26.6) 162.00 (18.79e395.33) 1,200 (130e2,990) Hepatic
17 19.80 (6.57e40.58) 138.60 (60.84e299.75) 1,010 (430e2,130) Renal
7 21.3 (6.8e31.0) 162.20 (62.47e394.25) 1,190 (440e2,980) Splenic
Aroua91 2007 70 22.0 (3.2e66.0) 463 (54e1,703) RL Switzerland, Hepatic
Note. Values are given as mean (range). FT ¼ ﬂuoroscopy time; DAP ¼ dose area product; CAK ¼ cumulative air kerma; ESD ¼ entrance
skin dose; RL ¼ reference level; GI ¼ gastrointestinal hemorrhage.
Minimizing radiation exposure during endovascular procedures 31Time on pedal. The foot pedal should be engaged only
when information is required. It is important to disengage
as soon as data acquisition is no longer relevant.
Low-dose setting. Most of the current commercially avail-
able imaging systems now offer half and/or low dose modes.
Experimental studies on phantoms have demonstrated that
routine use of the half dose setting is associated with an
entrance skin dose reduced almost by half,64 without
impairment of the image quality compared with full dose.
Digital subtraction angiography versus ﬂuoroscopic mode.
Digital subtraction angiography (DSA) allows high quality
loop acquisition with subtraction of non-vascular structures.
It is commonly used for diagnosis or documentation pur-
poses. However, DSA requires substantial additional radia-
tion exposure compared with standard ﬂuoroscopy.
Therefore, the use of ﬂuoroscopy must be preferred, and
DSA runs limited where possible.65 Digital storage of ﬂuo-
roscopic loops can replace most DSA runs.
Collimation. Reduction of the ﬁeld of view (FOV), through
appropriate vertical, horizontal, or iris collimation, allows
focus on the area of interest. It reduces scattered radiation
and therefore increases image accuracy. Moreover, it limits
the exposure of surrounding tissues. Radiation exposure is
decreased in proportion to the reduction of image size.66
Use of virtual collimation, when available, can help with
positioning the collimation leaves without ﬂuoroscopy.
Magniﬁcation. Magniﬁcation is used to obtain better visi-
bility by using a smaller FOV. Zooming is applied to the
image, making it easier to see the objects as they are bigger
to look at and also because monitors are used at relatively
long distances compared with their display capability.
Collimation is automatically adapted to protect surrounding
tissues, which also has an effect on removing scattered
radiation thus improving the image contrast. In general,
equipment is designed to increase the dose rate with the
reduction in FOV either approximately linearly or in a
quadratic way with the magniﬁcation factor. Image inten-
siﬁer detectors without correction have a decrease in
brightness gain in the selected area, which is compensated
for by generators to increase the dose production settings,
thus resulting in a dose rate increase by the square of the
magniﬁcation factor. For example, by switching from a FOV
of 30 cm to 17 cm, exposure increases by (30/17)2 ¼ 3.1
fold for the uncorrected image intensiﬁer.67 Typically, ﬂat
panels and corrected image intensiﬁers (by the gradualopening of an iris mechanism between the image intensiﬁer
and the camera) would experience an approximate linear
increase of dose rate with the magniﬁcation factor.
Furthermore, for an image intensiﬁer, there would be a
higher spatial resolution with the magniﬁcation factor. The
need for magniﬁcation can be limited by digital zooming
and the use of large display monitors.
Limit angulations. An exponential increase of scattered ra-
diation is observedwhen the gantry position is> 30 in left or
right anterior oblique angulation, or 15 in cranial angula-
tion.66 Angulation increases staff exposure, and image quality
deteriorates. Extreme gantry angulations should be avoided
or used shortly with adequate collimation when required.
Imaging chain geometry. The detector must be placed as
close to the patient as possible to avoid beam energy
dispersion and acquisition of a lowered signal (which would
result in an increase of dose production settings by gener-
ators).66 Table height must be adjusted so that operator’s
heads and chests are not too close to patients, who are the
main sources of scatter.
Auto-exposure settings. In modern angiography systems,
patient thickness is estimated to adjust dose production
settings (e.g. peak kilovolt and amperage) automatically in
order to decrease exposure and optimize the signal to noise
ratio. This allows constant image quality at the lowest dose.
Image quality can be adjusted with the help of the manu-
facturer to each physician’s speciﬁc daily practice and need,
so that procedures systematically start with the lowest
settings providing sufﬁcient image quality. Easy upgrade of
these settings must be available at any time from tableside
if better image quality is required during the procedure.
Flat panel detector technology. Flat panel detector tech-
nology is issued from solid state, widescreen display tech-
nology, widely used in liquid crystal display monitors. They
achieve a high level of radiographic performance thanks to
a high signal to noise ratio, wide dynamic signal range,
limited geometric distortion, and high uniformity of per-
formance across the FOV. Evidence in the literature suggests
that this technology can be associated with a reduction in
radiation exposure of up to 30% when compared with the
previous generation of devices using image intensiﬁers.68
Operator controlled imaging. Additional exposure can be
induced by misunderstandings or incorrect coordination
between radiographers and operators. A dose reduction of
approximately 30% has been reported during endovascular
32 A. Hertault et al.aortic repair (EVAR) procedures with complete operator
controlled imaging from tableside compared with radiog-
rapher controlled imaging.69
Pre-operative image analysis. Pre-operative image analysis
is mandatory to avoid the acquisition of unnecessary im-
ages. The old fashioned “diagnostic” run to begin inter-
ventional procedures is no longer required. Meticulous
planning of the procedure, with pre-operative imaging
analysis on a three dimensional (3D) workstation, allows for
the assessment of access routes, and for selecting speciﬁc
angulations and working positions. Consequently, direct
positioning of the gantry at the proper angulation can be
performed during the procedure, and thus ﬂuoroscopy or
DSA runs are minimized.
Advanced imaging applications: imaging fusion. Advanced
imaging applications, such as fusion imaging, are available
in most hybrid rooms. Several methods are described to
register a 3D volume, either from the pre-operative CT
angiography, or from a contrast enhanced cone beam CT
acquired during the procedure. The fused aortic 3D model
automatically follows table and detector movements, ﬂuo-
roscopy is thus only performed once the gantry and the
table are precisely positioned to visualize the working FOV.
This allows consequent dose savings. Indeed, a reduction of
up to 70% of the procedure’s global radiation has been
reported in complex EVAR supported by this technique.45,70Shielding
The main source of radiation to the operator is scattered
radiation. Scatter levels decrease by the inversed squared
distance from their main source, the patient. Incidentally,Figure 3. Illustrations of scatter radiation. Early reﬂection of the main b
the operator’s lower body. Scatter radiation decreases with the distanaccidental exposure to the main beam can occur, especially
when handling devices close to the FOV, but must be
avoided at all costs. Therefore, distance from the main
beam, for instance by working with longer sheaths, can help
decrease occupational exposure.
Scattered radiation is more important at the entrance
point of the beam to the patient, under the table. Most X-
ray energy deﬂected upward will be absorbed by the pa-
tient’s tissues, but X-rays deﬂected downward will not
encounter any obstacle. Thus, radiation levels are higher at
the operator’s legs, reinforcing the need for table mounted
lead skirts (Fig. 3).
Consequently, the tube should always be positioned un-
der the table, to avoid the highest scattered radiation being
directed at the operator’s head. Likewise, in lateral angu-
lations, operators should preferentially stand on the side of
the detector.
Protective garments are mandatory for all exposed staff
throughout procedures. A thickness of 0.5 mm lead equiv-
alent reduces the scattered radiation by 90%. A choice
between the available designs must be made taking into
consideration adequate coverage of the body and suitability
for daily practice. A two part lead apron (vest and kilt) offers
the advantages of covering the back and reducing the
weight on the shoulders. Lead aprons must be checked
annually under ﬂuoroscopy for cracks or holes in the pro-
tective lead that would decrease efﬁciency. Thyroid pro-
tection can be added to this outﬁt, which is recommended
for staff under the age of 40 years, and for those with a
monthly neck radiation exposure of >4 mSv in order to
prevent radiation induced thyroid cancer.71 Sterile protec-
tive gloves are available and provide attenuation of the
scattered radiation of 15e30%. However, they are ofteneam on the table and the patient leads to an increased exposure to
ce.
Minimizing radiation exposure during endovascular procedures 33misused for work within the main beam where they do not
offer protection, as (i) part of the X-ray beam goes through
the glove and is then endlessly reﬂected within; and (ii)
auto exposure algorithms react to the presence of attenu-
ating material by increasing the dose production settings to
maintain image brightness.71 Eye protection is highly rec-
ommended, especially as dose levels that induce RICs have
recently been revised downwards.13 Care must be given to
protective eyewear, which should also protect the side, as
scattered radiation comes from all directions.72 Eyes, head,
and chest protection can be reinforced by use of ceiling
mounted shields.73,74
Surgical protective drapes, containing bismuth and
barium, have been proposed to decrease occupational
exposure,75 and could be of use when operator’s hands
need to be close to the FOV.58 However, these drapes must
absolutely not encroach into the FOV, as it would increase
dose production, and the effect of redirecting scattered
radiation to the patient has not been evaluated.Follow up after accidental exposure
Overstepping one of the following thresholds during an
interventional procedure should automatically generate a
speciﬁc follow up because such doses might induce
injuries:29
 PSD >3 Gy;
 CAK >5 Gy;
 Kerma area-product >500 Gy.cm2.
A ﬂuoroscopy time >60 minutes, even if not a dose
value, should also raise concern.
If a patient is overexposed, the data need to be carefully
recorded in the patient’s medical record. The patient can be
then instructed to proceed to regular self examination of
the irradiated skin area and to notify the referring physi-
cians of the results. In the case of positive ﬁndings or
doubts about skin injuries, the patient must be referred to a
specialist dermatologist.Dose awareness
Daily practice optimization can be supported with the use of
real timedosimeters.Thesedevices, placedover the leadapron
at chest level, send real time radiation exposure information to
abase station. Live radiationdoseexposure canbeobservedon
the system’s monitor, with a basic and easily understandable
color transcription. This stimulates the operator’s concern on
radiation exposure, and represents a valuable tool in radio-
logical protection training.45,76
Collecting and storing dose data allows for continuous
self evaluation and thus helps to manage and control the
risk to patient and staff in the long-term. Dose data can be
collected with dose information tracking systems, called
dose archiving and communication systems, for example
DoseWatch (GE Healthcare, Little Chalfont, UK), Radi-
metrics (Bayer, Leverkusen, Germany), DAPcare (DAP
Technologies, Abingdon, UK), and DoseMonitor (PHSTechnologies Group, Scottsdale, AZ, USA). They automati-
cally collect the dosimetric information and perform sta-
tistical analysis. It can manage the dose history by patient,
and the patient’s safety, by sending alerts to the medical
staff. If available on several X-ray modalities in an institution
(ﬂuoroscopic devices, CT scan, etc.), it can provide a real
exposure to radiation history of the patient over time. This
system also offers the possibility of analyzing dose data by
ﬂuoroscopic devices or by procedure type, and so provides
comprehensive on site dose optimization support.CONCLUSION
With the rapid increase of endovascular procedures in the
ﬁeld of vascular surgery, basic knowledge about X-rays and
radiation protection is mandatory. With regard to radiation
exposure, initial training and education of vascular surgeons
are still heterogeneous and often incomplete. As evidenced
by the huge variability of published dose values, much
progress can still be achieved.With this aim, speciﬁc training
sessions at the beginning of careers, and refresher sessions
later, obviously play a key role. Speciﬁc attentionmust be paid
to the application of regulations of radiation dose reduction,
and to the monitoring of patients and personnel.CONFLICT OF INTEREST
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